Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

par Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Publié 2012

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

par Hashim, Dana, Engesæter, Birgit, Baadstrand Skare, Gry, Castle, Philip E., Bjørge, Tone, Tropé, Ameli, Nygård, Mari
Publié dans Br J Cancer (2020)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

par Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
Publié dans Cell Death Discov (2016)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma

par Prasmickaite, Lina, Engesæter, Birgit Ø., Skrbo, Nirma, Hellenes, Tina, Kristian, Alexandr, Oliver, Nina K., Suo, Zhenhe, Mælandsmo, Gunhild M.
Publié 2010

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention

par Lönnberg, Stefan, Andreassen, Trude, Engesæter, Birgit, Lilleng, Rune, Kleven, Cecilia, Skare, Annelie, Johansson, Karin, Fredheim, Christina Stangeland, Tropé, Ameli
Publié dans BMJ Open (2016)

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

par Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete
Publié dans Int J Cancer (2019)

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

par Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
Publié dans BMC Cancer (2015)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

par Seip, Kotryna, Fleten, Karianne G., Barkovskaya, Anna, Nygaard, Vigdis, Haugen, Mads H., Engesæter, Birgit Ø., Mælandsmo, Gunhild M., Prasmickaite, Lina
Publié dans Oncotarget (2016)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

par Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
Publié 2013

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

par Engesæter, Birgit, van Diermen Hidle, Bianca, Hansen, Mona, Moltu, Pia, Staby, Kjersti Mangseth, Borchgrevink-Persen, Siri, Vintermyr, Olav K., Lönnberg, Stefan, Nygård, Mari, Janssen, Emiel A. M., Castle, Philip E., Christiansen, Irene Kraus
Publié dans BMC Infect Dis (2016)